Apyx Medical (APYX) Non-Current Debt (2010 - 2026)

Apyx Medical's Non-Current Debt history runs 14 years deep, the most recent figure standing at $35.1 million for Q1 2026.

• Quarterly Non-Current Debt rose 2.81% year-over-year to $35.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.1 million (up 2.81% YoY) and the FY2025 annual result came in at $34.8 million, up 2.82% from the prior year.
• Non-Current Debt was $35.1 million for Q1 2026 at Apyx Medical, up from $34.8 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $35.1 million in Q1 2026 and bottomed at $8.8 million in Q1 2023.
• A 4-year average of $28.3 million and a median of $33.9 million in 2024 frame the typical range for Non-Current Debt.
• Peak annual rise in Non-Current Debt reached 280.57% in 2024, while the deepest fall reached 2.13% in 2024.
• Apyx Medical's Non-Current Debt stood at $33.2 million in 2023, then gained by 2.13% to $33.9 million in 2024, then grew by 2.82% to $34.8 million in 2025, then climbed by 0.68% to $35.1 million in 2026.
• Business Quant data shows APYX's Non-Current Debt at $35.1 million in Q1 2026, $34.8 million in Q4 2025, and $34.6 million in Q3 2025.